Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Sanofi-Aventis S.A.
(NY:
SNY
)
43.41
USD
UNCHANGED
Last Price
Updated: 5:16 PM EST, Dec 31, 2018
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Sanofi-Aventis S.A.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Should Investors Consider Buying These Top Health In March? 4 To Watch
Today 14:28 EST
Tags
Market News
From
StockMarket.com
Will Sanofi and GlaxoSmithKline Be Too Late to the Party With Their COVID Vaccine?
Today 7:03 EST
It's a real possibility.
Tags
SNY
JNJ
Market News
From
Motley Fool
News From The Vaccine World
March 04, 2021
Less than a year before the COVID-19 started its relentless march across the globe Novavax (NASDAQ: NVAX) was facing delisting from the ...
Tags
IAM Newswire
General
MRK
From
Benzinga
The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company
March 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
TTOO
MDXG
ACOR
From
Benzinga
Sanofi/Regneron's Dupixent Application For Asthma In Children Accepted For FDA Review
March 04, 2021
TheFDA has accepted for reviewthe supplemental marketing application seeking approval for Dupixent (dupilumab). It is an ...
Tags
Benzinga
Market News
Health Care
From
Benzinga
Is Moderna Stock A Buy After Crushing Quarterly, Guidance Expectations?
March 03, 2021
Moderna has emerged as a strong competitor after getting authorization for a coronavirus vaccine. But Moderna stock remains on a wild ride. Is Moderna stock a buy now?
From
Investor's Business Daily
Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: Report
March 02, 2021
U.S. President Joe Biden will announce thatMerck & Co(NYSE:MRK) will help manufacture its rivalJohnson & ...
Tags
SNY
Contracts
Biotech
From
Benzinga
Magenta Is Ready to Paint Your Portfolio Green
February 27, 2021
This clinical-stage biotech is looking to make stem cell transplantation faster, easier, and safer for both donors and patients.
Tags
BEAM
MGTA
BLUE
From
Motley Fool
Pandion Therapeutics Surges To Record High On Merck's $1.85 Billion Buyout
February 25, 2021
Pandion Therapeutics stock blasted to a record high Thursday on Merck's plan to buy the IPO stock for $1.85 billion. Pandion just recently wrapped its initial public offering in July.
From
Investor's Business Daily
Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11
February 23, 2021
Health Canada has approvedSanofi’s SA(NASDAQ:SNY) andRegeneron Pharmaceuticals ...
Tags
News
REGN
General
From
Benzinga
FDA Approves Regeneron/Sanofi's Libtayo For Front-Line Lung Cancer
February 23, 2021
The FDA approved expanded use ofRegeneron Pharmaceuticals Inc(NASDAQ:REGN) andSanofi’s ...
Tags
Market News
Benzinga
Biotech
From
Benzinga
FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants
February 23, 2021
Amid concerning virus variants, the FDA said it would quickly analyze any vaccine booster shots against COVID-19 variants. The ...
Tags
BNTX
Market News
AZN
From
Benzinga
Global Exception
February 22, 2021
Markets fell sharply over concern about high bond yields and potential inflation.
Tags
Stocks / Equities
Market News
From
Blogs - TalkMarkets
3 Green Flags for Novavax Investors, and 1 Red Flag
February 20, 2021
Since January 2020, Novavax has become 65-bagger. Is it still a buy?
Tags
Market News
NVAX
PFE
From
Motley Fool
Bristol-Myers, Sanofi Fined $834M In Hawaii Over Plavix: Bloomberg
February 16, 2021
Bristol-Myers Squibb Co(NYSE:BMY) andSanofi SA(NASDAQ:SNY) wereordered to paythe state of ...
Tags
Legal
Benzinga
News
From
Benzinga
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
February 14, 2021
Biotech stocks advanced in the week ended Feb. 12, thanks to market strength and company-specific catalysts. Small and mid-cap earnings, multiple conference presentations, data readouts, and a slew of...
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
February 14, 2021
Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap ...
Tags
OPK
RPRX
EXAS
From
Benzinga
Amicus Stock Plunges After Rare-Disease Drug Misses In Key Study
February 12, 2021
Amicus Therapeutics said Thursday its rare-disease treatment failed to outperform a standard drug on one key measure in a Phase 3 test. In response, FOLD stock plunged on Friday.
From
Investor's Business Daily
What Is Vaxart Worth Now?
February 12, 2021
The company can still produce returns without a COVID vaccine.
Tags
SNY
JNJ
VXRT
From
Motley Fool
Sanofi Offers Cash Buyout For Kiadis
February 12, 2021
Sanofi SA(NASDAQ:SNY) haslaunched a takeover offerforKiadis Pharma NV(OTC: KIADF) to represent an ...
Tags
Biotech
News
KIADF
From
Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
KRTX
IBB
MREO
From
Benzinga
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
February 10, 2021
Sanofi SA(NASDAQ:SNY) andRegeneron Pharmaceuticals Inc's(NASDAQ:REGN) immunotherapy Libtayo ...
Tags
News
Biotech
FDA
From
Benzinga
A Look Into Sanofi's Price Over Earnings
February 08, 2021
Looking into the current session, Sanofi Inc. (NASDAQ:SNY) shares are trading at $48.58, after a 0.77% increase. ...
Tags
BZI/PE
Market News
Earnings
From
Benzinga
A Look Into Sanofi's Debt
February 08, 2021
Over the past three months, shares of Sanofi (NASDAQ:SNY) decreased by 4.51%. Before we understand the importance of debt, let ...
Tags
Markets
Benzinga
Intraday Update
From
Benzinga
Should You Buy Lexicon Pharmaceuticals Stock?
February 06, 2021
Your portfolio could benefit from its group of soon-to-be-commercialized drugs.
Tags
Market News
LXRX
SNY
From
Motley Fool
Sanofi (SNY) Q4 2020 Earnings Call Transcript
February 05, 2021
SNY earnings call for the period ending December 31, 2020.
Tags
SNY
Market News
From
Motley Fool
What's Behind Regeneron's Stellar Q4 Update
February 05, 2021
The big biotech was firing on all cylinders, and getting strong growth out of its top-selling products.
Tags
SNY
REGN
Market News
From
Motley Fool
Regeneron's Q4 Double-Digit Top and Bottom-Line Growth Propelled By Higher Sales From Eylea And Dupixent
February 05, 2021
Regeneron Pharmaceuticals Inc(NASDAQ:REGN)reported fourth-quarter earningsof $9.53 per share, which beat the ...
Tags
Market News
Benzinga
Guidance
From
Benzinga
Sanofi: Q4 Earnings Insights
February 05, 2021
Shares of Sanofi (NASDAQ:SNY) rose 2.7% in pre-market trading after the company reported Q4 results. Quarterly ...
Tags
News
SNY
Market News
From
Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
PRTK
JNJ
IBB
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.